nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaprozin—osteoarthritis—Prednisone—systemic scleroderma	0.727	1	CpDpCtD
Oxaprozin—CYP2C9—cardial valve—systemic scleroderma	0.0205	0.388	CbGeAlD
Oxaprozin—PTGS2—skeletal joint—systemic scleroderma	0.00642	0.121	CbGeAlD
Oxaprozin—PTGS1—artery—systemic scleroderma	0.00281	0.0532	CbGeAlD
Oxaprozin—PTGS2—artery—systemic scleroderma	0.00269	0.0508	CbGeAlD
Oxaprozin—PTGS1—endothelium—systemic scleroderma	0.00238	0.0449	CbGeAlD
Oxaprozin—PTGS2—endothelium—systemic scleroderma	0.00227	0.0429	CbGeAlD
Oxaprozin—PTGS1—blood vessel—systemic scleroderma	0.00219	0.0414	CbGeAlD
Oxaprozin—PTGS2—Fluocinonide—Mometasone—systemic scleroderma	0.00219	0.624	CbGdCrCtD
Oxaprozin—PTGS2—blood vessel—systemic scleroderma	0.00209	0.0396	CbGeAlD
Oxaprozin—PTGS2—Fluticasone Propionate—Mometasone—systemic scleroderma	0.00132	0.376	CbGdCrCtD
Oxaprozin—PTGS1—connective tissue—systemic scleroderma	0.00112	0.0212	CbGeAlD
Oxaprozin—PTGS2—connective tissue—systemic scleroderma	0.00107	0.0203	CbGeAlD
Oxaprozin—PTGS1—smooth muscle tissue—systemic scleroderma	0.00103	0.0194	CbGeAlD
Oxaprozin—PTGS1—skin of body—systemic scleroderma	0.00101	0.0192	CbGeAlD
Oxaprozin—PTGS2—smooth muscle tissue—systemic scleroderma	0.000982	0.0186	CbGeAlD
Oxaprozin—PTGS2—skin of body—systemic scleroderma	0.00097	0.0183	CbGeAlD
Oxaprozin—CYP2C9—digestive system—systemic scleroderma	0.000889	0.0168	CbGeAlD
Oxaprozin—PTGS1—digestive system—systemic scleroderma	0.000812	0.0153	CbGeAlD
Oxaprozin—PTGS2—digestive system—systemic scleroderma	0.000776	0.0147	CbGeAlD
Oxaprozin—PTGS1—tendon—systemic scleroderma	0.000772	0.0146	CbGeAlD
Oxaprozin—PTGS2—tendon—systemic scleroderma	0.000738	0.014	CbGeAlD
Oxaprozin—PTGS1—lung—systemic scleroderma	0.000678	0.0128	CbGeAlD
Oxaprozin—PTGS2—lung—systemic scleroderma	0.000648	0.0122	CbGeAlD
Oxaprozin—Anxiety—Lisinopril—systemic scleroderma	0.000211	0.000974	CcSEcCtD
Oxaprozin—Dyspnoea—Leflunomide—systemic scleroderma	0.000211	0.000972	CcSEcCtD
Oxaprozin—Hypotension—Mycophenolic acid—systemic scleroderma	0.000211	0.000972	CcSEcCtD
Oxaprozin—Discomfort—Lisinopril—systemic scleroderma	0.00021	0.000966	CcSEcCtD
Oxaprozin—Lethargy—Methotrexate—systemic scleroderma	0.00021	0.000966	CcSEcCtD
Oxaprozin—Dyspepsia—Leflunomide—systemic scleroderma	0.000208	0.00096	CcSEcCtD
Oxaprozin—Pancreatitis—Prednisone—systemic scleroderma	0.000208	0.00096	CcSEcCtD
Oxaprozin—Vomiting—Mometasone—systemic scleroderma	0.000208	0.000958	CcSEcCtD
Oxaprozin—Dry mouth—Lisinopril—systemic scleroderma	0.000207	0.000956	CcSEcCtD
Oxaprozin—Sweating increased—Prednisone—systemic scleroderma	0.000207	0.000953	CcSEcCtD
Oxaprozin—Feeling abnormal—Azathioprine—systemic scleroderma	0.000207	0.000952	CcSEcCtD
Oxaprozin—Rash—Mometasone—systemic scleroderma	0.000206	0.00095	CcSEcCtD
Oxaprozin—Asthenia—Captopril—systemic scleroderma	0.000206	0.000949	CcSEcCtD
Oxaprozin—Dermatitis—Mometasone—systemic scleroderma	0.000206	0.000949	CcSEcCtD
Oxaprozin—Decreased appetite—Leflunomide—systemic scleroderma	0.000206	0.000948	CcSEcCtD
Oxaprozin—Confusional state—Lisinopril—systemic scleroderma	0.000205	0.000945	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000205	0.000944	CcSEcCtD
Oxaprozin—Headache—Mometasone—systemic scleroderma	0.000205	0.000944	CcSEcCtD
Oxaprozin—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000205	0.000943	CcSEcCtD
Oxaprozin—Insomnia—Mycophenolic acid—systemic scleroderma	0.000204	0.000941	CcSEcCtD
Oxaprozin—Oedema—Lisinopril—systemic scleroderma	0.000203	0.000937	CcSEcCtD
Oxaprozin—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000203	0.000937	CcSEcCtD
Oxaprozin—Pruritus—Captopril—systemic scleroderma	0.000203	0.000936	CcSEcCtD
Oxaprozin—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000203	0.000934	CcSEcCtD
Oxaprozin—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000203	0.000933	CcSEcCtD
Oxaprozin—Constipation—Leflunomide—systemic scleroderma	0.000202	0.000933	CcSEcCtD
Oxaprozin—Infection—Lisinopril—systemic scleroderma	0.000202	0.000931	CcSEcCtD
Oxaprozin—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000202	0.00093	CcSEcCtD
Oxaprozin—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000201	0.000928	CcSEcCtD
Oxaprozin—Somnolence—Mycophenolic acid—systemic scleroderma	0.000201	0.000925	CcSEcCtD
Oxaprozin—Shock—Lisinopril—systemic scleroderma	0.0002	0.000922	CcSEcCtD
Oxaprozin—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000199	0.000919	CcSEcCtD
Oxaprozin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000199	0.000918	CcSEcCtD
Oxaprozin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000199	0.000916	CcSEcCtD
Oxaprozin—Tachycardia—Lisinopril—systemic scleroderma	0.000198	0.000915	CcSEcCtD
Oxaprozin—Abdominal pain—Azathioprine—systemic scleroderma	0.000198	0.000913	CcSEcCtD
Oxaprozin—Body temperature increased—Azathioprine—systemic scleroderma	0.000198	0.000913	CcSEcCtD
Oxaprozin—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000197	0.000907	CcSEcCtD
Oxaprozin—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000197	0.000906	CcSEcCtD
Oxaprozin—Diarrhoea—Captopril—systemic scleroderma	0.000196	0.000905	CcSEcCtD
Oxaprozin—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000196	0.000904	CcSEcCtD
Oxaprozin—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000196	0.000904	CcSEcCtD
Oxaprozin—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000196	0.000902	CcSEcCtD
Oxaprozin—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000195	0.000901	CcSEcCtD
Oxaprozin—Feeling abnormal—Leflunomide—systemic scleroderma	0.000195	0.000899	CcSEcCtD
Oxaprozin—Nausea—Mometasone—systemic scleroderma	0.000194	0.000895	CcSEcCtD
Oxaprozin—Anorexia—Lisinopril—systemic scleroderma	0.000194	0.000893	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000194	0.000892	CcSEcCtD
Oxaprozin—Constipation—Mycophenolic acid—systemic scleroderma	0.000193	0.00089	CcSEcCtD
Oxaprozin—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000193	0.000889	CcSEcCtD
Oxaprozin—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000192	0.000884	CcSEcCtD
Oxaprozin—Hyperglycaemia—Prednisone—systemic scleroderma	0.000192	0.000883	CcSEcCtD
Oxaprozin—Hypotension—Lisinopril—systemic scleroderma	0.00019	0.000876	CcSEcCtD
Oxaprozin—Dizziness—Captopril—systemic scleroderma	0.00019	0.000875	CcSEcCtD
Oxaprozin—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000189	0.000872	CcSEcCtD
Oxaprozin—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000188	0.000869	CcSEcCtD
Oxaprozin—Urticaria—Leflunomide—systemic scleroderma	0.000188	0.000866	CcSEcCtD
Oxaprozin—Abdominal pain—Leflunomide—systemic scleroderma	0.000187	0.000862	CcSEcCtD
Oxaprozin—Body temperature increased—Leflunomide—systemic scleroderma	0.000187	0.000862	CcSEcCtD
Oxaprozin—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000187	0.00086	CcSEcCtD
Oxaprozin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000186	0.000857	CcSEcCtD
Oxaprozin—Myocardial infarction—Prednisone—systemic scleroderma	0.000186	0.000855	CcSEcCtD
Oxaprozin—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000185	0.000854	CcSEcCtD
Oxaprozin—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000185	0.000852	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000185	0.000851	CcSEcCtD
Oxaprozin—Insomnia—Lisinopril—systemic scleroderma	0.000184	0.000848	CcSEcCtD
Oxaprozin—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000184	0.000846	CcSEcCtD
Oxaprozin—Paraesthesia—Lisinopril—systemic scleroderma	0.000183	0.000841	CcSEcCtD
Oxaprozin—Vomiting—Captopril—systemic scleroderma	0.000183	0.000841	CcSEcCtD
Oxaprozin—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000182	0.000838	CcSEcCtD
Oxaprozin—Dyspnoea—Lisinopril—systemic scleroderma	0.000181	0.000835	CcSEcCtD
Oxaprozin—Rash—Captopril—systemic scleroderma	0.000181	0.000834	CcSEcCtD
Oxaprozin—Dermatitis—Captopril—systemic scleroderma	0.000181	0.000834	CcSEcCtD
Oxaprozin—Somnolence—Lisinopril—systemic scleroderma	0.000181	0.000833	CcSEcCtD
Oxaprozin—Headache—Captopril—systemic scleroderma	0.00018	0.000829	CcSEcCtD
Oxaprozin—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00018	0.000828	CcSEcCtD
Oxaprozin—Dyspepsia—Lisinopril—systemic scleroderma	0.000179	0.000825	CcSEcCtD
Oxaprozin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000178	0.000822	CcSEcCtD
Oxaprozin—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000178	0.000822	CcSEcCtD
Oxaprozin—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000178	0.000821	CcSEcCtD
Oxaprozin—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000178	0.000821	CcSEcCtD
Oxaprozin—Asthma—Methotrexate—systemic scleroderma	0.000178	0.000818	CcSEcCtD
Oxaprozin—Infection—Mycophenolate mofetil—systemic scleroderma	0.000177	0.000816	CcSEcCtD
Oxaprozin—Decreased appetite—Lisinopril—systemic scleroderma	0.000177	0.000815	CcSEcCtD
Oxaprozin—Eosinophilia—Methotrexate—systemic scleroderma	0.000176	0.00081	CcSEcCtD
Oxaprozin—Shock—Mycophenolate mofetil—systemic scleroderma	0.000175	0.000808	CcSEcCtD
Oxaprozin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000174	0.000804	CcSEcCtD
Oxaprozin—Pancreatitis—Methotrexate—systemic scleroderma	0.000174	0.000802	CcSEcCtD
Oxaprozin—Constipation—Lisinopril—systemic scleroderma	0.000174	0.000801	CcSEcCtD
Oxaprozin—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000174	0.000801	CcSEcCtD
Oxaprozin—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000172	0.000794	CcSEcCtD
Oxaprozin—Diarrhoea—Azathioprine—systemic scleroderma	0.000171	0.00079	CcSEcCtD
Oxaprozin—Haemoglobin—Prednisone—systemic scleroderma	0.000171	0.000787	CcSEcCtD
Oxaprozin—Nausea—Captopril—systemic scleroderma	0.000171	0.000786	CcSEcCtD
Oxaprozin—Haemorrhage—Prednisone—systemic scleroderma	0.00017	0.000783	CcSEcCtD
Oxaprozin—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00017	0.000783	CcSEcCtD
Oxaprozin—Asthenia—Leflunomide—systemic scleroderma	0.00017	0.000782	CcSEcCtD
Oxaprozin—Hallucination—Prednisone—systemic scleroderma	0.000169	0.000779	CcSEcCtD
Oxaprozin—Pancytopenia—Methotrexate—systemic scleroderma	0.000169	0.000777	CcSEcCtD
Oxaprozin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000168	0.000772	CcSEcCtD
Oxaprozin—Pruritus—Leflunomide—systemic scleroderma	0.000167	0.000772	CcSEcCtD
Oxaprozin—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000166	0.000767	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000166	0.000766	CcSEcCtD
Oxaprozin—Dysuria—Methotrexate—systemic scleroderma	0.000166	0.000765	CcSEcCtD
Oxaprozin—Dizziness—Azathioprine—systemic scleroderma	0.000166	0.000764	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000162	0.000747	CcSEcCtD
Oxaprozin—Asthenia—Mycophenolic acid—systemic scleroderma	0.000162	0.000746	CcSEcCtD
Oxaprozin—Diarrhoea—Leflunomide—systemic scleroderma	0.000162	0.000746	CcSEcCtD
Oxaprozin—Urticaria—Lisinopril—systemic scleroderma	0.000162	0.000744	CcSEcCtD
Oxaprozin—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000161	0.000743	CcSEcCtD
Oxaprozin—Abdominal pain—Lisinopril—systemic scleroderma	0.000161	0.000741	CcSEcCtD
Oxaprozin—Body temperature increased—Lisinopril—systemic scleroderma	0.000161	0.000741	CcSEcCtD
Oxaprozin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00016	0.000737	CcSEcCtD
Oxaprozin—Pruritus—Mycophenolic acid—systemic scleroderma	0.00016	0.000736	CcSEcCtD
Oxaprozin—Vomiting—Azathioprine—systemic scleroderma	0.000159	0.000734	CcSEcCtD
Oxaprozin—Pneumonia—Methotrexate—systemic scleroderma	0.000159	0.000734	CcSEcCtD
Oxaprozin—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000159	0.000732	CcSEcCtD
Oxaprozin—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000158	0.00073	CcSEcCtD
Oxaprozin—Drowsiness—Methotrexate—systemic scleroderma	0.000158	0.000729	CcSEcCtD
Oxaprozin—Rash—Azathioprine—systemic scleroderma	0.000158	0.000728	CcSEcCtD
Oxaprozin—Dermatitis—Azathioprine—systemic scleroderma	0.000158	0.000727	CcSEcCtD
Oxaprozin—Headache—Azathioprine—systemic scleroderma	0.000157	0.000723	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000157	0.000723	CcSEcCtD
Oxaprozin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000157	0.000723	CcSEcCtD
Oxaprozin—Dizziness—Leflunomide—systemic scleroderma	0.000157	0.000721	CcSEcCtD
Oxaprozin—Renal failure—Methotrexate—systemic scleroderma	0.000156	0.000717	CcSEcCtD
Oxaprozin—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000714	CcSEcCtD
Oxaprozin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000154	0.000712	CcSEcCtD
Oxaprozin—Stomatitis—Methotrexate—systemic scleroderma	0.000154	0.000711	CcSEcCtD
Oxaprozin—Conjunctivitis—Methotrexate—systemic scleroderma	0.000154	0.000709	CcSEcCtD
Oxaprozin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000152	0.000702	CcSEcCtD
Oxaprozin—Arrhythmia—Prednisone—systemic scleroderma	0.000152	0.0007	CcSEcCtD
Oxaprozin—Haematuria—Methotrexate—systemic scleroderma	0.000151	0.000695	CcSEcCtD
Oxaprozin—Vomiting—Leflunomide—systemic scleroderma	0.00015	0.000693	CcSEcCtD
Oxaprozin—Alopecia—Prednisone—systemic scleroderma	0.00015	0.000692	CcSEcCtD
Oxaprozin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000149	0.000688	CcSEcCtD
Oxaprozin—Rash—Leflunomide—systemic scleroderma	0.000149	0.000688	CcSEcCtD
Oxaprozin—Dermatitis—Leflunomide—systemic scleroderma	0.000149	0.000687	CcSEcCtD
Oxaprozin—Nausea—Azathioprine—systemic scleroderma	0.000149	0.000686	CcSEcCtD
Oxaprozin—Headache—Leflunomide—systemic scleroderma	0.000148	0.000683	CcSEcCtD
Oxaprozin—Agranulocytosis—Methotrexate—systemic scleroderma	0.000148	0.000681	CcSEcCtD
Oxaprozin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000147	0.000677	CcSEcCtD
Oxaprozin—Asthenia—Lisinopril—systemic scleroderma	0.000146	0.000672	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000146	0.000671	CcSEcCtD
Oxaprozin—Pruritus—Lisinopril—systemic scleroderma	0.000144	0.000663	CcSEcCtD
Oxaprozin—Vomiting—Mycophenolic acid—systemic scleroderma	0.000144	0.000662	CcSEcCtD
Oxaprozin—Haemoglobin—Methotrexate—systemic scleroderma	0.000143	0.000658	CcSEcCtD
Oxaprozin—Rash—Mycophenolic acid—systemic scleroderma	0.000142	0.000656	CcSEcCtD
Oxaprozin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000142	0.000655	CcSEcCtD
Oxaprozin—Haemorrhage—Methotrexate—systemic scleroderma	0.000142	0.000655	CcSEcCtD
Oxaprozin—Hepatitis—Methotrexate—systemic scleroderma	0.000142	0.000655	CcSEcCtD
Oxaprozin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000652	CcSEcCtD
Oxaprozin—Headache—Mycophenolic acid—systemic scleroderma	0.000141	0.000652	CcSEcCtD
Oxaprozin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000141	0.000649	CcSEcCtD
Oxaprozin—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000141	0.000649	CcSEcCtD
Oxaprozin—Nausea—Leflunomide—systemic scleroderma	0.000141	0.000648	CcSEcCtD
Oxaprozin—Vision blurred—Prednisone—systemic scleroderma	0.000139	0.000643	CcSEcCtD
Oxaprozin—Diarrhoea—Lisinopril—systemic scleroderma	0.000139	0.000641	CcSEcCtD
Oxaprozin—Ill-defined disorder—Prednisone—systemic scleroderma	0.000137	0.000633	CcSEcCtD
Oxaprozin—Anaemia—Prednisone—systemic scleroderma	0.000137	0.00063	CcSEcCtD
Oxaprozin—Angioedema—Prednisone—systemic scleroderma	0.000135	0.000623	CcSEcCtD
Oxaprozin—Dizziness—Lisinopril—systemic scleroderma	0.000134	0.00062	CcSEcCtD
Oxaprozin—Erythema multiforme—Methotrexate—systemic scleroderma	0.000134	0.000619	CcSEcCtD
Oxaprozin—Nausea—Mycophenolic acid—systemic scleroderma	0.000134	0.000618	CcSEcCtD
Oxaprozin—Malaise—Prednisone—systemic scleroderma	0.000133	0.000615	CcSEcCtD
Oxaprozin—Vertigo—Prednisone—systemic scleroderma	0.000133	0.000613	CcSEcCtD
Oxaprozin—Syncope—Prednisone—systemic scleroderma	0.000133	0.000612	CcSEcCtD
Oxaprozin—Tinnitus—Methotrexate—systemic scleroderma	0.000132	0.00061	CcSEcCtD
Oxaprozin—Loss of consciousness—Prednisone—systemic scleroderma	0.00013	0.000599	CcSEcCtD
Oxaprozin—Vomiting—Lisinopril—systemic scleroderma	0.000129	0.000596	CcSEcCtD
Oxaprozin—Rash—Lisinopril—systemic scleroderma	0.000128	0.000591	CcSEcCtD
Oxaprozin—Convulsion—Prednisone—systemic scleroderma	0.000128	0.000591	CcSEcCtD
Oxaprozin—Dermatitis—Lisinopril—systemic scleroderma	0.000128	0.00059	CcSEcCtD
Oxaprozin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000128	0.000589	CcSEcCtD
Oxaprozin—Hypertension—Prednisone—systemic scleroderma	0.000128	0.000589	CcSEcCtD
Oxaprozin—Headache—Lisinopril—systemic scleroderma	0.000127	0.000587	CcSEcCtD
Oxaprozin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000126	0.000581	CcSEcCtD
Oxaprozin—Anxiety—Prednisone—systemic scleroderma	0.000126	0.000579	CcSEcCtD
Oxaprozin—Alopecia—Methotrexate—systemic scleroderma	0.000126	0.000579	CcSEcCtD
Oxaprozin—Discomfort—Prednisone—systemic scleroderma	0.000124	0.000574	CcSEcCtD
Oxaprozin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000122	0.000562	CcSEcCtD
Oxaprozin—Dysgeusia—Methotrexate—systemic scleroderma	0.000121	0.000558	CcSEcCtD
Oxaprozin—Nausea—Lisinopril—systemic scleroderma	0.000121	0.000557	CcSEcCtD
Oxaprozin—Anaphylactic shock—Prednisone—systemic scleroderma	0.000121	0.000557	CcSEcCtD
Oxaprozin—Oedema—Prednisone—systemic scleroderma	0.000121	0.000557	CcSEcCtD
Oxaprozin—Infection—Prednisone—systemic scleroderma	0.00012	0.000553	CcSEcCtD
Oxaprozin—Shock—Prednisone—systemic scleroderma	0.000119	0.000548	CcSEcCtD
Oxaprozin—Tachycardia—Prednisone—systemic scleroderma	0.000118	0.000543	CcSEcCtD
Oxaprozin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000118	0.000543	CcSEcCtD
Oxaprozin—Hyperhidrosis—Prednisone—systemic scleroderma	0.000117	0.000538	CcSEcCtD
Oxaprozin—Vision blurred—Methotrexate—systemic scleroderma	0.000117	0.000537	CcSEcCtD
Oxaprozin—Anorexia—Prednisone—systemic scleroderma	0.000115	0.000531	CcSEcCtD
Oxaprozin—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000115	0.000529	CcSEcCtD
Oxaprozin—Anaemia—Methotrexate—systemic scleroderma	0.000114	0.000527	CcSEcCtD
Oxaprozin—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000113	0.000522	CcSEcCtD
Oxaprozin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000112	0.000518	CcSEcCtD
Oxaprozin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000112	0.000517	CcSEcCtD
Oxaprozin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000112	0.000514	CcSEcCtD
Oxaprozin—Malaise—Methotrexate—systemic scleroderma	0.000112	0.000514	CcSEcCtD
Oxaprozin—Vertigo—Methotrexate—systemic scleroderma	0.000111	0.000512	CcSEcCtD
Oxaprozin—Leukopenia—Methotrexate—systemic scleroderma	0.000111	0.00051	CcSEcCtD
Oxaprozin—Insomnia—Prednisone—systemic scleroderma	0.000109	0.000503	CcSEcCtD
Oxaprozin—Paraesthesia—Prednisone—systemic scleroderma	0.000108	0.0005	CcSEcCtD
Oxaprozin—Convulsion—Methotrexate—systemic scleroderma	0.000107	0.000494	CcSEcCtD
Oxaprozin—Dyspepsia—Prednisone—systemic scleroderma	0.000106	0.00049	CcSEcCtD
Oxaprozin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000106	0.000488	CcSEcCtD
Oxaprozin—Decreased appetite—Prednisone—systemic scleroderma	0.000105	0.000484	CcSEcCtD
Oxaprozin—Discomfort—Methotrexate—systemic scleroderma	0.000104	0.000479	CcSEcCtD
Oxaprozin—Constipation—Prednisone—systemic scleroderma	0.000103	0.000476	CcSEcCtD
Oxaprozin—Confusional state—Methotrexate—systemic scleroderma	0.000102	0.000469	CcSEcCtD
Oxaprozin—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000101	0.000465	CcSEcCtD
Oxaprozin—Infection—Methotrexate—systemic scleroderma	0.0001	0.000462	CcSEcCtD
Oxaprozin—Feeling abnormal—Prednisone—systemic scleroderma	9.95e-05	0.000459	CcSEcCtD
Oxaprozin—Thrombocytopenia—Methotrexate—systemic scleroderma	9.88e-05	0.000455	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Prednisone—systemic scleroderma	9.88e-05	0.000455	CcSEcCtD
Oxaprozin—Hyperhidrosis—Methotrexate—systemic scleroderma	9.76e-05	0.00045	CcSEcCtD
Oxaprozin—Anorexia—Methotrexate—systemic scleroderma	9.62e-05	0.000443	CcSEcCtD
Oxaprozin—Urticaria—Prednisone—systemic scleroderma	9.59e-05	0.000442	CcSEcCtD
Oxaprozin—Abdominal pain—Prednisone—systemic scleroderma	9.55e-05	0.00044	CcSEcCtD
Oxaprozin—Body temperature increased—Prednisone—systemic scleroderma	9.55e-05	0.00044	CcSEcCtD
Oxaprozin—Hypotension—Methotrexate—systemic scleroderma	9.43e-05	0.000435	CcSEcCtD
Oxaprozin—Insomnia—Methotrexate—systemic scleroderma	9.13e-05	0.000421	CcSEcCtD
Oxaprozin—Paraesthesia—Methotrexate—systemic scleroderma	9.06e-05	0.000418	CcSEcCtD
Oxaprozin—Dyspnoea—Methotrexate—systemic scleroderma	9e-05	0.000415	CcSEcCtD
Oxaprozin—Somnolence—Methotrexate—systemic scleroderma	8.97e-05	0.000414	CcSEcCtD
Oxaprozin—Dyspepsia—Methotrexate—systemic scleroderma	8.89e-05	0.000409	CcSEcCtD
Oxaprozin—Decreased appetite—Methotrexate—systemic scleroderma	8.77e-05	0.000404	CcSEcCtD
Oxaprozin—Asthenia—Prednisone—systemic scleroderma	8.67e-05	0.000399	CcSEcCtD
Oxaprozin—Pruritus—Prednisone—systemic scleroderma	8.55e-05	0.000394	CcSEcCtD
Oxaprozin—Feeling abnormal—Methotrexate—systemic scleroderma	8.32e-05	0.000383	CcSEcCtD
Oxaprozin—Diarrhoea—Prednisone—systemic scleroderma	8.26e-05	0.000381	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Methotrexate—systemic scleroderma	8.25e-05	0.00038	CcSEcCtD
Oxaprozin—Urticaria—Methotrexate—systemic scleroderma	8.02e-05	0.00037	CcSEcCtD
Oxaprozin—Dizziness—Prednisone—systemic scleroderma	7.99e-05	0.000368	CcSEcCtD
Oxaprozin—Abdominal pain—Methotrexate—systemic scleroderma	7.98e-05	0.000368	CcSEcCtD
Oxaprozin—Body temperature increased—Methotrexate—systemic scleroderma	7.98e-05	0.000368	CcSEcCtD
Oxaprozin—Vomiting—Prednisone—systemic scleroderma	7.68e-05	0.000354	CcSEcCtD
Oxaprozin—Rash—Prednisone—systemic scleroderma	7.62e-05	0.000351	CcSEcCtD
Oxaprozin—Dermatitis—Prednisone—systemic scleroderma	7.61e-05	0.000351	CcSEcCtD
Oxaprozin—Headache—Prednisone—systemic scleroderma	7.57e-05	0.000349	CcSEcCtD
Oxaprozin—Asthenia—Methotrexate—systemic scleroderma	7.24e-05	0.000334	CcSEcCtD
Oxaprozin—Nausea—Prednisone—systemic scleroderma	7.17e-05	0.000331	CcSEcCtD
Oxaprozin—Pruritus—Methotrexate—systemic scleroderma	7.14e-05	0.000329	CcSEcCtD
Oxaprozin—Diarrhoea—Methotrexate—systemic scleroderma	6.91e-05	0.000318	CcSEcCtD
Oxaprozin—Dizziness—Methotrexate—systemic scleroderma	6.67e-05	0.000308	CcSEcCtD
Oxaprozin—Vomiting—Methotrexate—systemic scleroderma	6.42e-05	0.000296	CcSEcCtD
Oxaprozin—Rash—Methotrexate—systemic scleroderma	6.36e-05	0.000293	CcSEcCtD
Oxaprozin—Dermatitis—Methotrexate—systemic scleroderma	6.36e-05	0.000293	CcSEcCtD
Oxaprozin—Headache—Methotrexate—systemic scleroderma	6.32e-05	0.000291	CcSEcCtD
Oxaprozin—Nausea—Methotrexate—systemic scleroderma	6e-05	0.000276	CcSEcCtD
